Barinthus Biotherapeutics plc. - BRNS

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$497.5M
QoQ value delta ($000)
+$487.1M (+4708.77%)
Implied price effect (QoQ)
+5481.86%
Shares
Total shares
7,901,825
QoQ shares delta
-1,270,349 (-13.85%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (BRNS)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 15 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
DC Funds, LP 449,607 642,204 30.95%
HSG Holding Ltd 42,216 1,420,473 2.23%
M&G Plc 5,197 5,197,349 0.03%
RENAISSANCE TECHNOLOGIES LLC 100 143,100 0.0%
Johns Hopkins University 85 122,237 0.01%
CITADEL ADVISORS LLC 83 118,799 0.0%
Baird Financial Group, Inc. 74 105,961 0.0%
Rangeley Capital, LLC 59 84,441 0.05%
HighTower Advisors, LLC 26 37,450 0.0%
RHUMBLINE ADVISERS 8 11,685 0.0%
GEODE CAPITAL MANAGEMENT, LLC 8 11,568 0.0%
MORGAN STANLEY 2 3,406 0.0%
UBS Group AG 2 3,152 0.0%